← Leaderboards
Alexander Keith Stewart
Mayo Clinic Arizona
$10,508,691
Attributed
$11,654,894
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2007–20$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$14,123,175 · 10
By mechanism
R01$7,254,204 · 4
U54$4,906,992 · 4
P50$1,961,979 · 2
Top collaborators
- Shaji Kunnathu Kumar5 shared
Others in their field
Top investigators on “Multiple Myeloma”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,380,351
- Larry Arthur$41,717,333
- Charles A Coltman · Southwest Oncology Group$36,988,659
- Kenneth C Anderson · Dana-Farber Cancer Inst$25,497,347
- Irene M. Ghobrial · Dana-Farber Cancer Inst$22,402,686
- Nilsa Del Carmen Ramirez · Ohio State University$22,287,552
Research focus
Multiple MyelomaPharmaceutical PreparationsCellsClinical TrialsResponseSamplingCell LineBaseGenomicsInnovationMolecularGenesMutationRna InterferenceBortezomibValidationPathway InteractionsClinicGenomeGene ExpressionRelapseFutureResistanceProteasome Inhibitor
Grant awards (36)
Project 1 - High Throughtput Drug Screening and Correlations with Mutational Status in Myeloma Cell Lines and Patient Samples$332,666
U54 · FY2020 · CA · contact PI
Project 1 - High Throughtput Drug Screening and Correlations with Mutational Status in Myeloma Cell Lines and Patient Samples$391,500
U54 · FY2019 · CA · contact PI
Clonal Evolution in Multiple Myeloma$254,798
P50 · FY2019 · CA · contact PI
Developmental Research Program$104,859
P50 · FY2019 · CA · contact PI
The Role of Cereblon Pathways in Myeloma$446,267
R01 · FY2018 · CA · contact PI
Clonal Evolution in Multiple Myeloma$301,270
P50 · FY2018 · CA · contact PI
Developmental Research Program$151,330
P50 · FY2018 · CA · contact PI
Overcoming Drug Resistance in Multiple Myeloma$2,468,281
U54 · FY2017 · CA · contact PI
Project 1 - High Throughtput Drug Screening and Correlations with Mutational Status in Myeloma Cell Lines and Patient Samples$753,737
U54 · FY2017 · CA · contact PI
Project 3 - Modeling Proteasome Inhibitor Response and Resistance in Cell Lines and Patient Samples with Single Cell Analysis of Subpopulations$709,561
U54 · FY2017 · CA · contact PI
The Role of Cereblon Pathways in Myeloma$446,267
R01 · FY2017 · CA · contact PI
Translation of Novel Therapeutic Targets in Multiple Myeloma$431,907
R01 · FY2017 · CA · contact PI
Clonal Evolution in Multiple Myeloma$275,781
P50 · FY2017 · CA · contact PI
Admin Core$251,247
U54 · FY2017 · CA · contact PI
Developmental Research Program$117,949
P50 · FY2017 · CA · contact PI
The Role of Cereblon Pathways in Myeloma$446,267
R01 · FY2016 · CA · contact PI
Translation of Novel Therapeutic Targets in Multiple Myeloma$431,907
R01 · FY2016 · CA · contact PI
Clonal Evolution in Multiple Myeloma$258,285
P50 · FY2016 · CA · contact PI
Developmental Research Program$117,340
P50 · FY2016 · CA · contact PI
The Role of Cereblon Pathways in Myeloma$459,038
R01 · FY2015 · CA · contact PI
Translation of Novel Therapeutic Targets in Multiple Myeloma$431,907
R01 · FY2015 · CA · contact PI
Clonal Evolution in Multiple Myeloma$261,545
P50 · FY2015 · CA · contact PI
Developmental Research Program$118,822
P50 · FY2015 · CA · contact PI
The Role of Cereblon Pathways in Myeloma$494,568
R01 · FY2014 · CA · contact PI
Translation of Novel Therapeutic Targets in Multiple Myeloma$418,950
R01 · FY2014 · CA · contact PI
Translation of Novel Therapeutic Targets in Multiple Myeloma$447,029
R01 · FY2013 · CA · contact PI
A Genome Wide RNAi Vulnerability Map for Myeloma$246,800
R01 · FY2012 · CA · contact PI
The Molecular Basis for Bortezomib Activity$295,041
R01 · FY2011 · CA · contact PI
A Genome Wide RNAi Vulnerability Map for Myeloma$246,908
R01 · FY2011 · CA · contact PI
The Molecular Basis for Bortezomib Activity$304,166
R01 · FY2010 · CA · contact PI
A Genome Wide RNAi Vulnerability Map for Myeloma$254,967
R01 · FY2010 · CA · contact PI
The Molecular Basis for Bortezomib Activity$304,166
R01 · FY2009 · CA · contact PI
A Genome Wide RNAi Vulnerability Map for Myeloma$254,717
R01 · FY2009 · CA · contact PI
The Molecular Basis for Bortezomib Activity$304,166
R01 · FY2008 · CA · contact PI
A Genome Wide RNAi Vulnerability Map for Myeloma$270,000
R01 · FY2008 · CA · contact PI
The Molecular Basis for Bortezomib Activity$319,166
R01 · FY2007 · CA · contact PI